Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines

被引：0
|
作者：
Dutra-Oliveira, A. [1 ]
Monteiro, R. Q. [1 ]
Mariano-Oliveira, A. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941 Rio De Janeiro, Brazil
来源：
THROMBOSIS RESEARCH | 2012年 / 129卷
关键词：
D O I：
10.1016/S0049-3848(12)70131-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S190 / S191
页数：5
相关论文
共 50 条
  • [1] Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines
    Dutra-Oliveira, Angelica
    Monteiro, Robson Q.
    Mariano-Oliveira, Andrea
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 421 (02) : 221 - 227
  • [2] Protease-activated receptor-2 (PAR-2) induces VEGF production through ERK1/2 pathways in human glioblastoma cell lines
    Oliveira, A. M.
    Oliveira, A. D.
    Monteiro, R. Q.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 891 - 891
  • [3] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [4] Protease-activated receptor-2 (PAR2) in the airways
    Cocks, TM
    Moffatt, JD
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) : 183 - 191
  • [5] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [6] Does protease-activated receptor-2 (PAR2) influence muscle development and regeneration?
    Esfandouni, N. Taghavi
    Mackie, E.
    Pagel, C.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S218 - S219
  • [7] Predictive value of protease-activated receptor-2 (PAR2) in cervical cancer metastasis
    He, Shengnan
    Xu, Meiquan
    Xiong, Zhen
    Hu, Ye
    Huo, Qin
    Lu, Jingxiao
    Lin, Yuntao
    Yang, Lan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1415 - 1424
  • [8] Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
    Shearer, Andrew M.
    Rana, Rajashree
    Austin, Karyn
    Baleja, James D.
    Nguyen, Nga
    Bohm, Andrew
    Covic, Lidija
    Kuliopulos, Athan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 23188 - 23198
  • [9] Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Yau, Mei-Kwan
    Liu, Ligong
    Fairlie, David P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7477 - 7497
  • [10] Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)
    Shearer, Andrew M.
    Austin, Karyn
    Guha, Srijoy
    Nga Nguyen
    Looby, Richard
    Clappin, Allyson
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    HEPATOLOGY, 2014, 60 : 587A - 587A
12345